On April 9, 2025, the Ministry of Labor, Health, Solidarity and Families published the Order setting DRG tariffs and tariffs for other packages and supplements for 2025. New tariffs are applicable from March 1, 2025.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 21st of April, we plan to work on 19 projects. Review the complete list of planned activities in this post.

In March 2025, Small Business Research Initiative (SBRI) Healthcare announced innovations awarded through Competition 26 Phase 3 for Urgent & Emergency Care, launched in July 2024. A total of £3.9 million was allocated for the development of nine innovations, of which eight were concerned with e-health and one with in-vitro diagnostics.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Julian et al. investigated how EU stakeholders perceive key challenges in implementing EU Regulation 2021/2282 on Health Technology Assessment. Drawing on survey data and structured discussions at the 2024 European Access Academy, the authors found that 65.5 % of respondents reported insufficient expert involvement in joint assessments, only 37.9 % anticipated faster national decision-making, and views on conflict-of-interest transparency were mixed. Stakeholders prioritized earlier and broader expert engagement, stronger EMA–EU HTA coordination, and increased national-level support.

In April 2025, the proposals to improve the New Methods framework processes were published by the Norwegian authorities. The key changes include revised enter pathways and selection criteria for assessment of medical devices within the framework. The proposals are open for public comment until May 18, 2025.

On April 8, 2025, the National Union of Health Insurance Funds issued an update to the Common Classification of Medical Procedures (CCAM), which serves as a reimbursement nomenclature for medical procedures in hospital and ambulatory settings. Changes include the introduction of new procedure codes, provisional registration of several procedure codes, and modification of existing services. Newly introduced procedure codes concern cardiovascular and peripheral vascular procedures, interventional radiology, ENT, and others. The update takes effect on July 1, 2025.

In March 2025, the entity managing the DRG system in Switzerland, SwissDRG, announced that they would be accepting applications for changes in the DRG system from June 2, 2025, until July 14, 2025. The results of the DRG applications made in 2025 will be reflected in the 2027 version of the SwissDRG.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Friedericy et al. assessed the environmental footprint of inhalation anaesthetics in Dutch hospitals and surveyed anaesthesiologists on practice patterns. A comprehensive 2019 bottom-up evaluation of anaesthetic agent procurement across the Netherlands was conducted. The analysis revealed relatively low greenhouse gas emissions, largely due to the widespread preference for intravenous anaesthesia and the limited use of inhalation-based techniques.

On April 4, 2025, NHS England published the final NHS Payment Scheme (NHSPS) for the 2025/26 financial year (starting on April 1st), defining payment mechanisms for the provision of NHS-funded hospital and ambulatory care and some public health services. No significant changes were made to the general payment model. The key changes include the introduction of reimbursement for activities from Community Diagnostic Centres and a new Best Practice Tariff to incentivize shifting suitable procedures from day case/hospital to outpatient settings.

On April 1, 2025, the revised EBM (German Uniform Evaluation Standard) catalog for the second quarter of 2025 came into force. The main changes introduced concern updates of the contents (services legends, preambles of several EBM subchapters) and the introduction of new EBM codes related to follow-up and evaluation of another reimbursable health app and second-opinion consultations.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Polmear et al. examined the growing application of Bayesian statistical methods in orthopedic research, highlighting their advantages over traditional P value-based approaches. The authors emphasized how Bayesian analysis can offer more nuanced interpretations in clinical contexts. Through practical examples ‒ such as diagnostic decision-making in prosthetic joint infection and comparative analysis from the orthopedic trial ‒ the review illustrated key Bayesian concepts and offered guidance for critically evaluating such studies.

MTRC is pleased to announce the release of its latest White Paper: "Reimbursement and HTA - Things You Might Be Missing". This document highlights the challenges market access professionals face in staying current with reimbursement and HTA developments and examines how the MTRC Market Access Monitor can help bridge these gaps.